-
21
Use of Glucagon-Like Peptide-1 Receptor Agonists Does Not Increase the Risk of Cancer in Patients with Type 2 Diabetes Mellitus
Published 2025-01-01Subjects: “…diabetes mellitus, type 2…”
Get full text
Article -
22
Contribution of type 2 diabetes to major adverse cardiovascular events (MACE) in a long-term observational study with different stages of atherosclerosis
Published 2025-01-01Subjects: “…Diabetes mellitus type 2…”
Get full text
Article -
23
Short-term impact of glycaemic control and intravitreal ranibizumab treatment on serum cytokine levels and diabetic macular edema in patients with unregulated blood glucose
Published 2022-12-01Subjects: “…diabetes mellitus, type 2…”
Get full text
Article